Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Table 1 Demographic characteristics of all 53 patients
CharacteristicValue
Sex, No.male/female: 26/27
Age, median (range), yr63.0 (31-83)
Tumor location, No.Esophagus/stomach/duodenum: 4/47/2
Table 2 Histopathological diagnosis
Esophagus (n = 4)Stomach (n = 47)Duodenum (n = 2)Total(n = 53)
GIMT445049
GIST034034
Leiomyoma2305
Schwannoma1203
Spindle-cell tumor1607
Ectopic pancreas0101
Hamartoma0011
Intramural developmental cyst0101
Brunner’s adenoma0011
Table 3 Details of 53 patients
Resected tumors(n = 34)Unresected tumors (n = 19)Total (n = 53)GIST (n = 34)
Follow-up period, median (range), mo24.9 (6.6-210)36.5 (11.2-183.6)31.7 (6.6-210)27.3 (6.6-210)
EUS sessions, median (range)3 (2-8)4 (2-13)3 (2-13)3 (2-11)
Tumor diameter at initial EUS, median (range), mm19.5 (10-30)19.0 (11.5-44.8)19.1 (10-44.8)19.0 (10.9-44.8)
Tumor diameter before surgery or FNA, median (range), mm28.0 (20-43.1)22.8 (15.2-52.1)25.3 (13.7-52.1)26.7 (13.7-52.1)
Time from the final EUS to surgery, median (range)3.8 mo (22d-16.3 mo)---
Table 4 Details of 34 patients with gastrointestinal submucosal tumors
Extremely low plus low risk (n = 28)Intermediate risk(n = 3)High risk (n = 3)Total (n = 34)
Follow-up period, median (range), mo31.0 (6.6-210)47.3 (11.2-49.9)12.4 (7.4-16.7)27.3 (6.6-210)
Initial tumor diameter, median (range), mm18.6 (10.9-30.0)28.5 (20.0-44.8)25.5 (14.0-27.3)19.0 (10.9-44.8)
Doubling time, median (range), mo24.0 (2.0-183.6)17.1 (6.1-19.4)3.9 (0.8-10.4)17.2 (0.8-183.6)
Table 5 Tumors other than gastrointestinal submucosal tumors
No. of patientFollow-up period, median (range), moDoubling time, median (range), mo
Leiomyoma547.1 (10.7-137.2)231.2 (21.3-1303.8)
Schwannoma350.1 (24.3-71.7)104.7 (3.9-305.4)
Ectopic pancreas166.5274.9
Hamartoma199.661.2
Intramural developmental cyst129.549.0
Brunner’s adenoma130.6134.7
Table 6 Comparison according to diagnosis
Doubling time (mo), medianP value
GIST vs Leiomyoma + schwannoma17.2 vs 204.20.005
High risk vs Intermediate risk3.9 vs 17.10.127
Intermediate risk vs Extremely low + low risk17.1 vs 24.00.423
High risk vs Extremely low + low risk3.9 vs 24.00.033
High + intermediate risk vs Extremely low + low risk8.2 vs 24.00.047